Page 20 - Service Testing News Today

Bayer lost a fifth of its market value at one point Monday, after the German pharmaceutical and agricultural group said it had ended a late-stage test for...

By Chris Wack MediciNova shares were up 14% to $2.30 after the company reported positive data for its phase 2 clinical trial of MN-166 ibudilast in...

Vertex's COO said a trial of its new pain pill hadn't tested the drug against a placebo.

Efforts to diversify clinical trials aim to ensure devices, drugs and prevention work for all

By David Sachs A drug to treat chronic liver disease developed by Ipsen and Genfit has gained a positive result in its phase-three trial, the companies said....

New trial data for Novo Nordisk's Wegovy drug could herald a paradigm shift in weight-loss treatments.

Health-care companies rose as traders continued to chase gains in obesity-drug makers. Novo Nordisk shares rose slightly after the Danish drug giant said its...

Eli Lilly also scores, analysts say, as trial results leave door open for Zepbound to top Wegovy’s benefits

Closely watched clinical trial could help boost insurance coverage of GLP-1 drugs, analysts say

Also: Bad and good results this earnings season, new tax rules, stock picks and how you too can be a mortgage lender.